Shamima Akhter

Shamima Akhter

Auto-generated profile, based on publicly available information

Shamima Akhter

The University of Texas MD Anderson Cancer Center, Houston, TX

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2023 in Informatics in Medicine Unlocked
Verified
Journal Article
Open access
KHKamrul Hasan
Kamrul Hasan
SAShamima Akhter
Shamima Akhter
KFKaniz Fatema
Kaniz Fatema
RHRezaul Hossain
Rezaul Hossain
TSTamanna Sultana
Tamanna Sultana
MUMonir Uzzaman
Monir Uzzaman

2 November 2013 in Progressive Agriculture
Verified
Journal Article
Open access
PDF file
HUH Uddin
H Uddin
MRMha Rashid
Mha Rashid
SAS Akhter
S Akhter
This study was conducted to estimate the relative profitability of Maize production under different farm size groups. Data were collected from randomly selected 74 maize growing farmers of which 25 were small, 32 were medium and 17 were large considering the scope and potentials of maize production at Kishoregonj district. To achieve the objectives of the study, descriptive statistical techniques such as sum, average, standard deviation etc, were used. The major findings of the study showed that per hectare average total costs were Tk. 30,147.54, Tk. 31,892.00 and Tk. 34,059.00 for small, medium and large farmers, respectively. Per hectare gross return from maize production were Tk. 61,730.00, Tk. 79,716.00 and Tk. 75,707.00 for small, medium and large farmers, respectively. Per hectare gross margins from maize production was estimated at Tk. 36,836.00, Tk. 53,096.00 and Tk. 46,871.00 for small, medium and large farmers, respectively. Per hectare average net returns of maize were estimated at Tk. 31,583.00, Tk. 47,823.00 and Tk. 41,648.00 for small, medium and large farmers, respectively. The findings of the study revealed that medium farmers earned higher profit than those of small and large farmers.DOI: http://dx.doi.org/10.3329/pa.v21i1-2.16781 Progress. Agric. 21(1 & 2): 247 - 252, 2010

1 September 2026 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
ASAsmita Shah
Asmita Shah
TLTimothy G. Lerch
Timothy G. Lerch
GAGourab Acharjee
Gourab Acharjee
GRGrace A. R. Rohaley
Grace A. R. Rohaley
SAShamima Akhter
Shamima Akhter
Torsten HegmannTorsten Hegmann
Torsten Hegmann
Herein, we present the fabrication of freestanding cellulose nanocrystal (CNC) films exhibiting blue, green, red, and, in combination, near‐white right‐handed CPL (RCPL) through covalent grafting of achiral fluorophores to CNCs via Steglich esterification. The weakly‐twisted CNCs, hierarchically organized through evaporation‐induced self‐assembly, act as chiral scaffolds enforcing the supramolecular chirality. The ensuing composite CNC films display dye‐specific photoluminescence with maximum negative luminescence dissymmetry () values of −0.15, −0.16, and −0.11 for blue, green, and red emissive films, respectively, indicative of preferential right‐handed emission. Morphological evaluation via scanning electron microscopy (SEM) reveals well‐defined Bouligand arches, and studies by polarized optical microscopy (POM) fingerprint textures, each confirming the preservation of chiral nematic ordering across all emissive films. Notably, by integration of all three fluorescent dyes within the CNC matrix, near‐white CPL was achieved by color mixing, as corroborated by CIE 1931 chromaticity analysis with values ranging from 0.05 to 0.10 over the visible spectral region, with 90% permanence of the fluorescence over a 12‐h irradiation period. This approach establishes the basic framework for generating mechanically and thermally robust CPL‐active, principally bio‐renewable chiral CNC materials and optical elements for advanced displays, optoelectronic devices, and chiroptical sensing platforms.

15 September 2023 in Clinical Cancer Research
Verified
Journal Article
Open access
SAShamima Akhter
Shamima Akhter
TXTongxin Xie
Tongxin Xie
Simone AnfossiSimone Anfossi
Simone Anfossi
AAAdewale Adebayo
Adewale Adebayo
FGFrederico Omar Gleber-Netto
Frederico Omar Gleber-Netto
Moran AmitMoran Amit
Moran Amit
Solid tumors sculpt their microenvironments to maximize their growth and metastatic potential. Previously, we showed that the loss of p53 in head and neck squamous cell carcinoma (HNSCC) cells reprograms tumor-associated neurons (TANs) towards an adrenergic phenotype and promotes tumor progression. The impact of this neuronal reprogramming on the tumor immune microenvironment remains undefined. To understand how neuronal transdifferentiation regulates the antitumor immune response, we tested our hypothesis that shuttling cancer-derived microRNAs to TANs via exosomes induces an immunosuppressive neuronal phenotype in the tumor microenvironment (TME) that undermines the anti-tumor immune response. We first checked the stability of HNSCC-derived exosomes and their cargo (i.e., microRNA [miR]). Then, we assessed the miR transfer to TANs both in vitro and in vivo using HNSCC syngeneic models, and we measured miR enrichment in the trigeminal ganglia neurons after exosome injection. We used RNA sequencing to assess the trigeminal ganglia’s transcriptome and a single-cell multiplex enzyme-linked immunosorbent assay to evaluate the functional status of CD8+ T cells cocultured with cancer cells with or without TANs. Cancer cell–derived exosomes and their cargo were stable for up to 14 days in the TME and were taken up by TANs both in vitro and in vivo. The injection of exosomes into the peripheral nerves led to miR324a and miR21 upregulation in the associated trigeminal ganglionic soma, indicating that cancer-derived exosomes mediated crosstalk between cancer and neuronal cells. The RNA sequencing of human and mouse neuronal cells transfected with miR21 and miR324a revealed many differentially regulated immune pathways, including the neuroinflammation, T-cell receptor signaling, toll-like receptor, macrophage differentiation and growth inhibition, antigen-processing, interleukin (IL)-6, programmed cell death protein 1/programmed death-ligand 1, acute-phase response signaling, IL-8, wound-healing, IL-9, IL-17A, IL-23, IL-2, IL-10, IL-7, IL-4, IL-33, IL-36, CD28, CD40, signal transducer and activator of transcription 3, and nuclear factor kappa B pathways. Furthermore, the single-cell proteomic assay indicated that the CD8+ T cells cultured with neuronal cells were functionally distinct from the activated T cells co-cultured with neuronal and cancer cells. The co-culture with cancer cells and neuronal cells significantly downregulated the effector phenotype markers (e.g., granzyme B, interferon gamma, tumor necrosis factor alpha) in activated T cells, indicating that the interaction of cancer cells with neurons regulates the immunosuppressive TME. Our study showed the ability of cancer-derived exosomes to reprogram neurons and downstream to that to regulate the tumor immune environment in HNSCC. Our data suggest that transdifferentiating of TANs induce immunosuppression by direct inhibitory signal and immune checkpoint expression in the TME of HNSCC. Future studies are needed to investigate TANs as a potential target in immune oncology. Citation Format: Shamima Akhter, Tongxin Xie, Simone Anfossi, Adewale Adebayo, Frederico O. Gleber-Netto, Melanie Winkle, Masayoshi Shimitzu, Weilu Zhao, Megan L. Uhelski, Yan Li, George A. Calin, Moran Amit. Harmony between transdifferentiated neuron and immunosuppressive tumor microenvironment [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-068.

15 September 2023 in Clinical Cancer Research
Verified
Journal Article
Open access
MGMica D. E. Glaun
Mica D. E. Glaun
FGFrederico Omar Gleber-Netto
Frederico Omar Gleber-Netto
PNPriyadharsini Nagarajan
Priyadharsini Nagarajan
TXTongxin Xie
Tongxin Xie
SAShamima Akhter
Shamima Akhter
Moran AmitMoran Amit
Moran Amit
Immunosuppression is a major risk and prognostic factor for cutaneous squamous cell carcinoma (cSCC). Immune checkpoint inhibition is approved for the treatment of cSCC, yet most immunosuppressed patients are ineligible for immunotherapy. Better understanding on the tumor microenvironment of cSCC in the context of immunosuppression (i.e., organ transplant recipients, patients with hematological malignancies or autoimmune diseases or acquired immunodeficiencies such as HIV) is of utmost importance for proper implementation of immunotherapy as a therapeutic alternative for these patients. In this study, we characterized the immune cell phenotype of cSCC from immunocompetent (IC) and immunosuppressed (IS) patients treated at two Cancer Centers. We also compared the immune phenotype changes through the steps of skin carcinogenesis between IC and IS patients, and among individuals with distinct causes for immunosuppression. To evaluate the TME dynamics during tumorigenesis, we analyzed specimen of normal epithelium, keratinocytic intraepidermal neoplasia (including carcinoma in situ and actinic keratosis), or invasive cSCC. The analysis of cSCC tumor microenvironment was performed by multiplex immunofluorescence (Opal 12-Color), CyTOF and single-cell RNA sequencing. Our analysis revealed that densities of CD68+ and effector T-cells are diminished in IS patients compared with IC. An analysis of precursor lesions revealed that the density of tumoral CD8+LAG3+ T-cells in patients with hematological malignancies was significantly lower than in patients with other types of immunosuppression. Compared with patients with other types of immunosuppression, patients with hematological malignancies had a higher density of stromal CD4+ T cells in precursor lesions but a lower density of CD20+ B cells. Overall, IS patients had worse outcomes than IC patients, and the densities of CD68+ and CD8+LAG3+ cells were prognostic in this cohort. CD8+LAG3+ was significantly associated with DSS of IS patients indicating the impact of dysfunctional cytotoxic T cells on these patients’ survival. Our findings provide a detailed insight into the underlying immune alterations from tumor inception through growth and invasion, in patients with different types of immunosuppression. This dataset will serve as a benchmark data to guide clinical trials aiming to treat this patient population and provide a potential rationale for designing safer immunotherapy clinical trials for the population of IS patients with cSCC or other head and neck cancers. Citation Format: Mica D. E. Glaun, Frederico O. Gleber-Netto, Priyadharsini Nagarajan, Tongxin Xie, Shamima Akhter, Yu Han Chen, Erez Baruch N. Baruch, Michael K. Wong, Emily Y. Chu, Kenneth Y. Tsai, Elsa R. Flores, Deborah A. Silverman, Ryan P. Goepfert, Murat Cobanoglu, Jared Burks, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross, Moran Amit. The evolution of the tumor immune microenvironment in immunosuppressed patients with cutaneous squamous cell carcinoma [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-074.